[Advances in immunotherapy for relapsed-refractory diffuse large B cell lymphoma]

Zhonghua Xue Ye Xue Za Zhi. 2014 Dec;35(12):1131-3. doi: 10.3760/cma.j.issn.0253-2727.2014.12.020.

[Article in Chinese]

Authors

Jiao Chen¹, Lijuan Li¹, Liansheng Zhang¹

Affiliation

¹ Department of Hamotology Lanzhou University Second Hospital, Lanzhou 730000, China.

PMID: 25543714
DOI: 10.3760/cma.j.issn.0253-2727.2014.12.020

No abstract available

MeSH terms

Humans
Immunotherapy*
Lymphoma, Large B-Cell, Diffuse*
Recurrence